Paid Clinical Trials District of Columbia
Discover 543 paid clinical trials in District of Columbia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Observational StudyContinuum of Care in Hospitalized Patients With Opioid Use Disorder and Infectious Complications From Drug Use
Sponsor:
Elana Rosenthal
Location:
Code:
NCT06513156
Conditions
Opioid Use Disorder
Injection Related Infections
Stimulant Use Disorder
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Integrated Infectious Diseases and Substance Use Disorder Clinic (IC)
NavSTAR-CHOICE (NS)
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
Sponsor:
University of North Carolina, Chapel Hill
Location:
Code:
NCT03554356
Conditions
Barrett Esophagus
Intestinal Metaplasia
Esophageal Dysplasia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CryoBalloon Focal Ablation System
BMS-986365 vs. Investigator's ChoiceA Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
Sponsor:
Celgene
Location:
Code:
NCT06764485
Conditions
Metastatic Castration-resistant Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BMS-986365
Enzalutamide
Abiraterone
Docetaxel
Predinsone/Prednisolone
OfatumumabPharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT06869785
Conditions
Relapsing Multiple Sclerosis (RMS)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ofatumumab approved dose
Ofatumumab new dose
Observational StudyFetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
Sponsor:
University of Utah
Location:
Code:
NCT05767385
Conditions
Congenital Heart Disease in Children
Hypoxia
Neurodevelopmental Disorders
Complex Congenital Heart Disease
Eligibility Criteria
Sex: Female
Age: 0 - 52
Healthy Volunteers: Not accepted
Interventions
Single Arm
Neonatal Neurobehavioral Scale
PF-07220060 with LetrozoleStudy of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Sponsor:
Pfizer
Location:
Code:
NCT06760637
Conditions
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PF-07220060
letrozole
abemaciclib
palbociclib
ribociclib
IVUS Guided TreatmentIMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact
Sponsor:
Medstar Health Research Institute
Location:
Code:
NCT04221815
Conditions
Atherosclerosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Eagle Eye Platinum digital IVUS catheter with optional SyncVision
Resolute Onyx Drug Eluting Stent
Onyx Frontier Drug Eluting Stent
Onyx TruStar Drug Eluting Stent
Onyx TruCor Drug Eluting Stent
Mirror TherapyExamining Brain Changes Using Functional Magnetic Resonance Imaging (fMRI) in Amputees With Phantom Limb Pain Following Mirror Therapy
Sponsor:
United States Department of Defense
Location:
Code:
NCT00662415
Conditions
Phantom Limb Pain
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
mirror-box treatment
observation
Asthma CareHospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma Care
Sponsor:
Kavita Parikh
Location:
Code:
NCT05991115
Conditions
Asthma
Asthma in Children
Eligibility Criteria
Sex: All
Age: 4 - 12
Healthy Volunteers: Not accepted
Interventions
Hospital to Home Transition (H2H)